135 related articles for article (PubMed ID: 36600045)
1. Concurrent prognostic utility of lymph node count and lymph node density for men with pathological node-positive prostate cancer.
Masterson JM; Luu M; Naser-Tavakolian A; Freedland SJ; Sandler H; Zumsteg ZS; Daskivich TJ
Prostate Cancer Prostatic Dis; 2024 Jun; 27(2):264-271. PubMed ID: 36600045
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Lymph Node Dissection in Metastatic Prostate Cancer Patients Treated with Radical Prostatectomy: A Contemporary Analysis of Survival and Early Postoperative Outcomes.
Mazzone E; Preisser F; Nazzani S; Tian Z; Bandini M; Gandaglia G; Fossati N; Montorsi F; Graefen M; Shariat SF; Saad F; Briganti A; Karakiewicz PI
Eur Urol Oncol; 2019 Sep; 2(5):541-548. PubMed ID: 31411992
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of an Improved Pathological Nodal Staging System in Men with Prostate Cancer.
Daskivich TJ; Luu M; Freedland SJ; Sandler H; Spratt DE; Zumsteg ZS
J Urol; 2022 Mar; 207(3):581-591. PubMed ID: 34694160
[TBL] [Abstract][Full Text] [Related]
4. Head-to-head comparison of lymph node density and number of positive lymph nodes in stratifying the outcome of patients with lymph node-positive prostate cancer submitted to radical prostatectomy and extended lymph node dissection.
Passoni NM; Abdollah F; Suardi N; Gallina A; Bianchi M; Tutolo M; Fossati N; Gandaglia G; Salonia A; Freschi M; Rigatti P; Montorsi F; Briganti A
Urol Oncol; 2014 Jan; 32(1):29.e21-8. PubMed ID: 23490908
[TBL] [Abstract][Full Text] [Related]
5. Adequate lymph node dissection is essential for accurate nodal staging in intrahepatic cholangiocarcinoma: A population-based study.
Zhu J; Liu C; Li H; Ren H; Cai Y; Lan T; Wu H
Cancer Med; 2023 Apr; 12(7):8184-8198. PubMed ID: 36645113
[TBL] [Abstract][Full Text] [Related]
6. Disease-specific survival after radical lymphadenectomy for penile cancer: prediction by lymph node count and density.
Li ZS; Yao K; Chen P; Zou ZJ; Qin ZK; Liu ZW; Li YH; Zhou FJ; Han H
Urol Oncol; 2014 Aug; 32(6):893-900. PubMed ID: 24994488
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years.
Suardi N; Gandaglia G; Gallina A; Di Trapani E; Scattoni V; Vizziello D; Cucchiara V; Bertini R; Colombo R; Picchio M; Giovacchini G; Montorsi F; Briganti A
Eur Urol; 2015 Feb; 67(2):299-309. PubMed ID: 24571959
[TBL] [Abstract][Full Text] [Related]
8. Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study.
Steuber T; Budäus L; Walz J; Zorn KC; Schlomm T; Chun F; Ahyai S; Fisch M; Sauter G; Huland H; Graefen M; Haese A
BJU Int; 2011 Jun; 107(11):1755-61. PubMed ID: 20942833
[TBL] [Abstract][Full Text] [Related]
9. Lymph node dissection during robotic-assisted laparoscopic prostatectomy: comparison of lymph node yield and clinical outcomes when including common iliac nodes with standard template dissection.
Katz DJ; Yee DS; Godoy G; Nogueira L; Chong KT; Coleman JA
BJU Int; 2010 Aug; 106(3):391-6. PubMed ID: 20089113
[TBL] [Abstract][Full Text] [Related]
10. Prognosis of patients with pelvic lymph node (LN) metastasis after radical prostatectomy: value of extranodal extension and size of the largest LN metastasis.
Passoni NM; Fajkovic H; Xylinas E; Kluth L; Seitz C; Robinson BD; Rouprêt M; Chun FK; Lotan Y; Roehrborn CG; Crivelli JJ; Karakiewicz PI; Scherr DS; Rink M; Graefen M; Schramek P; Briganti A; Montorsi F; Tewari A; Shariat SF
BJU Int; 2014 Oct; 114(4):503-10. PubMed ID: 24053552
[TBL] [Abstract][Full Text] [Related]
11. Biochemical recurrence after robot-assisted extended pelvic lymphadenectomy for prostate cancer.
Chenam A; Ruel N; Pal S; Barlog J; Lau C; Wilson T; Yuh B
Can J Urol; 2018 Jun; 25(3):9340-9348. PubMed ID: 29900823
[TBL] [Abstract][Full Text] [Related]
12. Pelvic/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography/computed tomography.
Rigatti P; Suardi N; Briganti A; Da Pozzo LF; Tutolo M; Villa L; Gallina A; Capitanio U; Abdollah F; Scattoni V; Colombo R; Freschi M; Picchio M; Messa C; Guazzoni G; Montorsi F
Eur Urol; 2011 Nov; 60(5):935-43. PubMed ID: 21840116
[TBL] [Abstract][Full Text] [Related]
13. KLK3 and TMPRSS2 for molecular lymph-node staging in prostate cancer patients undergoing radical prostatectomy.
Lunger L; Retz M; Bandur M; Souchay M; Vitzthum E; Jäger M; Weirich G; Schuster T; Autenrieth M; Kübler H; Maurer T; Thalgott M; Herkommer K; Koll F; Gschwend JE; Nawroth R; Heck MM
Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):362-369. PubMed ID: 32978525
[TBL] [Abstract][Full Text] [Related]
14. More lymph node dissection improves survival in patients with newly diagnosed lymph node-positive penile cancer.
Mao W; Huang X; Kong M; Fan J; Geng J
Int Urol Nephrol; 2019 Apr; 51(4):641-654. PubMed ID: 30758771
[TBL] [Abstract][Full Text] [Related]
15. Molecular Lymph Node Status for Prognostic Stratification of Prostate Cancer Patients Undergoing Radical Prostatectomy with Extended Pelvic Lymph Node Dissection.
Heck MM; Retz M; Bandur M; Souchay M; Vitzthum E; Weirich G; Schuster T; Autenrieth M; Kübler H; Maurer T; Thalgott M; Herkommer K; Gschwend JE; Nawroth R
Clin Cancer Res; 2018 May; 24(10):2342-2349. PubMed ID: 29463560
[No Abstract] [Full Text] [Related]
16. Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study.
Heck MM; Retz M; Bandur M; Souchay M; Vitzthum E; Weirich G; Mollenhauer M; Schuster T; Autenrieth M; Kübler H; Maurer T; Thalgott M; Herkommer K; Gschwend JE; Nawroth R
Eur Urol; 2014 Aug; 66(2):222-9. PubMed ID: 23465520
[TBL] [Abstract][Full Text] [Related]
17. Patterns of Pelvic Lymph Node Dissection at the Time of Radical Prostatectomy for Low-risk Men.
Chalfin HJ; Feng Z; Trock BJ; Partin AW
Urology; 2017 Jun; 104():143-149. PubMed ID: 28232176
[TBL] [Abstract][Full Text] [Related]
18. Small-volume lymph node involvement and biochemical recurrence after robot-assisted radical prostatectomy with extended lymph node dissection in prostate cancer.
Morizane S; Honda M; Shimizu R; Teraoka S; Nishikawa R; Tsounapi P; Kimura Y; Iwamoto H; Hikita K; Takenaka A
Int J Clin Oncol; 2020 Jul; 25(7):1398-1404. PubMed ID: 32333202
[TBL] [Abstract][Full Text] [Related]
19. Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC).
Tilki D; Chandrasekar T; Capitanio U; Ciancio G; Daneshmand S; Gontero P; Gonzalez J; Haferkamp A; Hohenfellner M; Huang WC; Linares Espinós E; Lorentz A; Martinez-Salamanca JI; Master VA; McKiernan JM; Montorsi F; Novara G; Pahernik S; Palou J; Pruthi RS; Rodriguez-Faba O; Russo P; Scherr DS; Shariat SF; Spahn M; Terrone C; Vera-Donoso C; Zigeuner R; Libertino JA; Evans CP
Urol Oncol; 2018 Feb; 36(2):79.e11-79.e17. PubMed ID: 29129353
[TBL] [Abstract][Full Text] [Related]
20. Differing risk of cancer death among patients with lymph node metastasis after radical prostatectomy and pelvic lymph node dissection: identification of risk categories according to number of positive nodes and Gleason score.
Schiavina R; Borghesi M; Brunocilla E; Manferrari F; Fiorentino M; Vagnoni V; Baccos A; Pultrone CV; Rocca GC; Rizzi S; Martorana G
BJU Int; 2013 Jun; 111(8):1237-44. PubMed ID: 23331345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
